ID   ALG6_HUMAN              Reviewed;         507 AA.
AC   Q9Y672; B3KMU2; Q5SXR9; Q9H3I0;
DT   27-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   10-MAY-2017, entry version 153.
DE   RecName: Full=Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase;
DE            EC=2.4.1.267;
DE   AltName: Full=Asparagine-linked glycosylation protein 6 homolog;
DE   AltName: Full=Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase;
DE   AltName: Full=Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase;
GN   Name=ALG6; ORFNames=My046;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT CDG1C VAL-333.
RX   PubMed=10359825; DOI=10.1073/pnas.96.12.6982;
RA   Imbach T., Burda P., Kuhnert P., Wevers R.A., Aebi M., Berger E.G.,
RA   Hennet T.;
RT   "A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6
RT   gene causes carbohydrate-deficient glycoprotein syndrome type-Ic.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:6982-6987(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal brain;
RA   Mao Y.M., Xie Y., Zheng Z.H.;
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-304.
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   VARIANTS CDG1C HIS-131; ARG-308 AND VAL-333.
RX   PubMed=11106564; DOI=10.1016/S0002-9440(10)64830-4;
RA   Westphal V., Murch S., Kim S., Srikrishna G., Winchester B., Day R.,
RA   Freeze H.H.;
RT   "Reduced heparan sulfate accumulation in enterocytes contributes to
RT   protein-losing enteropathy in a congenital disorder of
RT   glycosylation.";
RL   Am. J. Pathol. 157:1917-1925(2000).
RN   [8]
RP   VARIANTS CDG1C VAL-333 AND PRO-478, AND VARIANT SER-304.
RX   PubMed=10914684; DOI=10.1007/s004390000293;
RA   Imbach T., Gruenewald S., Schenk B., Burda P., Schollen E.,
RA   Wevers R.A., Jaeken J., de Klerk J.B.C., Berger E.G., Matthijs G.,
RA   Aebi M., Hennet T.;
RT   "Multi-allelic origin of congenital disorder of glycosylation (CDG)-
RT   Ic.";
RL   Hum. Genet. 106:538-545(2000).
RN   [9]
RP   VARIANT CDG1C ILE-299 DEL, AND VARIANT SER-304.
RX   PubMed=10924277; DOI=10.1006/mgme.2000.3017;
RA   Westphal V., Schottstaedt C., Marquardt T., Freeze H.H.;
RT   "Analysis of multiple mutations in the hALG6 gene in a patient with
RT   congenital disorder of glycosylation Ic.";
RL   Mol. Genet. Metab. 70:219-223(2000).
RN   [10]
RP   VARIANT SER-304.
RX   PubMed=11558905; DOI=10.1007/s100380170038;
RA   Vuillaumier-Barrot S., Le Bizec C., Durand G., Seta N.;
RT   "The T911C (F304S) substitution in the human ALG6 gene is a common
RT   polymorphism and not a causal mutation of CDG-Ic.";
RL   J. Hum. Genet. 46:547-548(2001).
RN   [11]
RP   VARIANTS CDG1C ILE-170 AND LEU-444 DEL.
RX   PubMed=11134235; DOI=10.1136/jmg.38.1.14;
RA   de Lonlay P., Seta N., Barrot S., Chabrol B., Drouin V., Gabriel B.M.,
RA   Journel H., Kretz M., Laurent J., Le Merrer M., Leroy A., Pedespan D.,
RA   Sarda P., Villeneuve N., Schmitz J., van Schaftingen E., Matthijs G.,
RA   Jaeken J., Koerner C., Munnich A., Saudubray J.-M., Cormier-Daire V.;
RT   "A broad spectrum of clinical presentations in congenital disorders of
RT   glycosylation I: a series of 26 cases.";
RL   J. Med. Genet. 38:14-19(2001).
RN   [12]
RP   VARIANT CDG1C GLU-227.
RX   PubMed=12357336; DOI=10.1038/sj.ejhg.5200858;
RA   Schollen E., Martens K., Geuzens E., Matthijs G.;
RT   "DHPLC analysis as a platform for molecular diagnosis of congenital
RT   disorders of glycosylation (CDG).";
RL   Eur. J. Hum. Genet. 10:643-648(2002).
RN   [13]
RP   CHARACTERIZATION OF VARIANT SER-304.
RX   PubMed=11875054; DOI=10.1093/hmg/11.5.599;
RA   Westphal V., Kjaergaard S., Schollen E., Martens K., Gruenewald S.,
RA   Schwartz M., Matthijs G., Freeze H.H.;
RT   "A frequent mild mutation in ALG6 may exacerbate the clinical severity
RT   of patients with congenital disorder of glycosylation Ia (CDG-Ia)
RT   caused by phosphomannomutase deficiency.";
RL   Hum. Mol. Genet. 11:599-604(2002).
RN   [14]
RP   VARIANT CDG1C HIS-131.
RX   PubMed=14517965; DOI=10.1002/humu.9195;
RA   Westphal V., Xiao M., Kwok P.-Y., Freeze H.H.;
RT   "Identification of a frequent variant in ALG6, the cause of congenital
RT   disorder of glycosylation-Ic.";
RL   Hum. Mutat. 22:420-421(2003).
CC   -!- FUNCTION: Adds the first glucose residue to the lipid-linked
CC       oligosaccharide precursor for N-linked glycosylation. Transfers
CC       glucose from dolichyl phosphate glucose (Dol-P-Glc) onto the
CC       lipid-linked oligosaccharide Man(9)GlcNAc(2)-PP-Dol.
CC   -!- CATALYTIC ACTIVITY: Dolichyl beta-D-glucosyl phosphate + D-Man-
CC       alpha-(1->2)-D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-[D-Man-alpha-
CC       (1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-(1->2)-D-Man-alpha-(1->6))-
CC       D-Man-alpha-(1->6)]-D-Man-beta-(1->4)-D-GlcNAc-beta-(1->4)-D-
CC       GlcNAc-diphosphodolichol = D-Glc-alpha-(1->3)-D-Man-alpha-(1->2)-
CC       D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-[D-Man-alpha-(1->2)-D-Man-
CC       alpha-(1->3)-(D-Man-alpha-(1->2)-D-Man-alpha-(1->6))-D-Man-alpha-
CC       (1->6)]-D-Man-beta-(1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-
CC       diphosphodolichol + dolichyl phosphate.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- DISEASE: Congenital disorder of glycosylation 1C (CDG1C)
CC       [MIM:603147]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:10359825,
CC       ECO:0000269|PubMed:10914684, ECO:0000269|PubMed:10924277,
CC       ECO:0000269|PubMed:11106564, ECO:0000269|PubMed:11134235,
CC       ECO:0000269|PubMed:12357336, ECO:0000269|PubMed:14517965}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the ALG6/ALG8 glucosyltransferase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF102851; AAD41466.1; -; mRNA.
DR   EMBL; AF063604; AAG43163.1; -; mRNA.
DR   EMBL; AK022700; BAG51104.1; -; mRNA.
DR   EMBL; AL592218; CAI18961.1; -; Genomic_DNA.
DR   EMBL; AL049636; CAI18961.1; JOINED; Genomic_DNA.
DR   EMBL; AL049636; CAI22829.1; -; Genomic_DNA.
DR   EMBL; AL592218; CAI22829.1; JOINED; Genomic_DNA.
DR   EMBL; CH471059; EAX06571.1; -; Genomic_DNA.
DR   EMBL; BC001253; AAH01253.1; -; mRNA.
DR   CCDS; CCDS30735.1; -.
DR   RefSeq; NP_037471.2; NM_013339.3.
DR   UniGene; Hs.258501; -.
DR   ProteinModelPortal; Q9Y672; -.
DR   BioGrid; 118970; 10.
DR   IntAct; Q9Y672; 1.
DR   STRING; 9606.ENSP00000360149; -.
DR   CAZy; GT57; Glycosyltransferase Family 57.
DR   iPTMnet; Q9Y672; -.
DR   PhosphoSitePlus; Q9Y672; -.
DR   SwissPalm; Q9Y672; -.
DR   BioMuta; ALG6; -.
DR   DMDM; 21263380; -.
DR   EPD; Q9Y672; -.
DR   MaxQB; Q9Y672; -.
DR   PaxDb; Q9Y672; -.
DR   PeptideAtlas; Q9Y672; -.
DR   PRIDE; Q9Y672; -.
DR   DNASU; 29929; -.
DR   Ensembl; ENST00000371108; ENSP00000360149; ENSG00000088035.
DR   GeneID; 29929; -.
DR   KEGG; hsa:29929; -.
DR   UCSC; uc021oof.1; human.
DR   CTD; 29929; -.
DR   DisGeNET; 29929; -.
DR   GeneCards; ALG6; -.
DR   H-InvDB; HIX0000661; -.
DR   HGNC; HGNC:23157; ALG6.
DR   HPA; HPA062536; -.
DR   MalaCards; ALG6; -.
DR   MIM; 603147; phenotype.
DR   MIM; 604566; gene.
DR   neXtProt; NX_Q9Y672; -.
DR   Orphanet; 79320; ALG6-CDG.
DR   PharmGKB; PA134925619; -.
DR   eggNOG; KOG2575; Eukaryota.
DR   eggNOG; ENOG410XQK1; LUCA.
DR   HOGENOM; HOG000195048; -.
DR   HOVERGEN; HBG024331; -.
DR   InParanoid; Q9Y672; -.
DR   KO; K03848; -.
DR   PhylomeDB; Q9Y672; -.
DR   TreeFam; TF314522; -.
DR   BRENDA; 2.4.1.267; 2681.
DR   Reactome; R-HSA-446193; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; ALG6; human.
DR   GeneWiki; ALG6; -.
DR   GenomeRNAi; 29929; -.
DR   PRO; PR:Q9Y672; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000088035; -.
DR   CleanEx; HS_ALG6; -.
DR   ExpressionAtlas; Q9Y672; baseline and differential.
DR   Genevisible; Q9Y672; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0042281; F:dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity; IBA:GO_Central.
DR   GO; GO:0004583; F:dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity; TAS:Reactome.
DR   GO; GO:0046527; F:glucosyltransferase activity; IDA:MGI.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome.
DR   GO; GO:0006490; P:oligosaccharide-lipid intermediate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006487; P:protein N-linked glycosylation; IDA:MGI.
DR   InterPro; IPR004856; Glyco_trans_ALG6/ALG8.
DR   PANTHER; PTHR12413; PTHR12413; 1.
DR   Pfam; PF03155; Alg6_Alg8; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Congenital disorder of glycosylation;
KW   Disease mutation; Endoplasmic reticulum; Glycosyltransferase;
KW   Membrane; Polymorphism; Reference proteome; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    507       Dolichyl pyrophosphate Man9GlcNAc2 alpha-
FT                                1,3-glucosyltransferase.
FT                                /FTId=PRO_0000174156.
FT   TRANSMEM      4     24       Helical. {ECO:0000255}.
FT   TRANSMEM    115    135       Helical. {ECO:0000255}.
FT   TRANSMEM    144    164       Helical. {ECO:0000255}.
FT   TRANSMEM    173    193       Helical. {ECO:0000255}.
FT   TRANSMEM    227    247       Helical. {ECO:0000255}.
FT   TRANSMEM    298    318       Helical. {ECO:0000255}.
FT   TRANSMEM    324    344       Helical. {ECO:0000255}.
FT   TRANSMEM    362    382       Helical. {ECO:0000255}.
FT   TRANSMEM    388    408       Helical. {ECO:0000255}.
FT   TRANSMEM    438    458       Helical. {ECO:0000255}.
FT   TRANSMEM    473    493       Helical. {ECO:0000255}.
FT   VARIANT     131    131       Y -> H (in CDG1C; dbSNP:rs35383149).
FT                                {ECO:0000269|PubMed:11106564,
FT                                ECO:0000269|PubMed:14517965}.
FT                                /FTId=VAR_022511.
FT   VARIANT     170    170       S -> I (in CDG1C).
FT                                {ECO:0000269|PubMed:11134235}.
FT                                /FTId=VAR_022512.
FT   VARIANT     226    226       K -> N (in dbSNP:rs35604168).
FT                                /FTId=VAR_055493.
FT   VARIANT     227    227       G -> E (in CDG1C).
FT                                {ECO:0000269|PubMed:12357336}.
FT                                /FTId=VAR_022513.
FT   VARIANT     299    299       Missing (in CDG1C).
FT                                {ECO:0000269|PubMed:10924277}.
FT                                /FTId=VAR_013441.
FT   VARIANT     304    304       F -> S (common polymorphism; may
FT                                exacerbate the clinical severity of
FT                                patients with CDG1A; reduces the ability
FT                                to rescue defective glycosylation of an
FT                                alg6-deficient strain of S. cerevisiae
FT                                during rapid growth; dbSNP:rs4630153).
FT                                {ECO:0000269|PubMed:10914684,
FT                                ECO:0000269|PubMed:10924277,
FT                                ECO:0000269|PubMed:11558905,
FT                                ECO:0000269|PubMed:11875054,
FT                                ECO:0000269|PubMed:16710414}.
FT                                /FTId=VAR_013442.
FT   VARIANT     308    308       S -> R (in CDG1C).
FT                                {ECO:0000269|PubMed:11106564}.
FT                                /FTId=VAR_022514.
FT   VARIANT     333    333       A -> V (in CDG1C).
FT                                {ECO:0000269|PubMed:10359825,
FT                                ECO:0000269|PubMed:10914684,
FT                                ECO:0000269|PubMed:11106564}.
FT                                /FTId=VAR_013443.
FT   VARIANT     444    444       Missing (in CDG1C).
FT                                {ECO:0000269|PubMed:11134235}.
FT                                /FTId=VAR_022515.
FT   VARIANT     478    478       S -> P (in CDG1C).
FT                                {ECO:0000269|PubMed:10914684}.
FT                                /FTId=VAR_013444.
FT   CONFLICT    111    111       F -> L (in Ref. 2; AAG43163).
FT                                {ECO:0000305}.
FT   CONFLICT    374    374       T -> P (in Ref. 2; AAG43163).
FT                                {ECO:0000305}.
FT   CONFLICT    394    394       T -> P (in Ref. 2; AAG43163).
FT                                {ECO:0000305}.
FT   CONFLICT    457    457       T -> A (in Ref. 2; AAG43163).
FT                                {ECO:0000305}.
SQ   SEQUENCE   507 AA;  58181 MW;  6558E0A318597D03 CRC64;
     MEKWYLMTVV VLIGLTVRWT VSLNSYSGAG KPPMFGDYEA QRHWQEITFN LPVKQWYFNS
     SDNNLQYWGL DYPPLTAYHS LLCAYVAKFI NPDWIALHTS RGYESQAHKL FMRTTVLIAD
     LLIYIPAVVL YCCCLKEIST KKKIANALCI LLYPGLILID YGHFQYNSVS LGFALWGVLG
     ISCDCDLLGS LAFCLAINYK QMELYHALPF FCFLLGKCFK KGLKGKGFVL LVKLACIVVA
     SFVLCWLPFF TEREQTLQVL RRLFPVDRGL FEDKVANIWC SFNVFLKIKD ILPRHIQLIM
     SFCFTFLSLL PACIKLILQP SSKGFKFTLV SCALSFFLFS FQVHEKSILL VSLPVCLVLS
     EIPFMSTWFL LVSTFSMLPL LLKDELLMPS VVTTMAFFIA CVTSFSIFEK TSEEELQLKS
     FSISVRKYLP CFTFLSRIIQ YLFLISVITM VLLTLMTVTL DPPQKLPDLF SVLVCFVSCL
     NFLFFLVYFN IIIMWDSKSG RNQKKIS
//
